Folic Acid Enables Targeting Delivery of Lipodiscs by Circumventing IgM-Mediated Opsonization

Deciphering Protein Corona by scFv-Based Affinity Chromatography

(2021) Yuxiu Chu et al.   NANO LETTERS

Apolipoprotein E Binding Drives Structural and Compositional Rearrangement of mRNA-Containing Lipid Nanoparticles

(2021) Federica Sebastiani et al.   ACS Nano

Self-Adjuvant Effect by Manipulating the Bionano Interface of Liposome-Based Nanovaccines

(2021) Zhuxuan Jiang et al.   NANO LETTERS

Regulation of in vivo delivery of nanomedicines by herbal medicines

(2021) Juan Guan et al.   ADVANCED DRUG DELIVERY REVIEWS

Interrogating preclinical study of liposomes: The effect of mouse strain reexamined

(2021) Juan Guan et al.   JOURNAL OF CONTROLLED RELEASE

Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages

(2021) Pearl Moharil et al.   Acta Pharmaceutica Sinica B

Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona

(2021) Yang He et al.   Acta Pharmaceutica Sinica B

Natural IgM dominates in vivo performance of liposomes

(2020) Tianhao Ding et al.   JOURNAL OF CONTROLLED RELEASE

Structural insights into immunoglobulin M

(2020) Yaxin Li et al.   SCIENCE

Exploiting the folate receptor α in oncology

(2020) Mariana Scaranti et al.   Nature Reviews Clinical Oncology

Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals

(2020) Gergely Tibor Kozma et al.   ADVANCED DRUG DELIVERY REVIEWS

Interrogation of Folic Acid-Functionalized Nanomedicines: The Regulatory Roles of Plasma Proteins Reexamined

(2020) Huan Wang et al.   ACS Nano

Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia

(2020) Alaeddin Khalil et al.   HAEMATOLOGICA

Engineering precision nanoparticles for drug delivery

(2020) Michael J. Mitchell et al.   NATURE REVIEWS DRUG DISCOVERY

Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age?

(2019) Michael J. Birrer et al.   ONCOLOGIST

Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b

(2019) Thomas H. Sharp et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PEGylated liposomes: immunological responses

(2019) Marwa Mohamed et al.   SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS

Folate-conjugated nanovehicles: Strategies for cancer therapy

(2019) Batoul Farran et al.   Materials Science & Engineering C-Materials for Biological Applications

Nanodisk-based glioma-targeted drug delivery enabled by a stable glycopeptide

(2018) Huan Wang et al.   JOURNAL OF CONTROLLED RELEASE

Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona

(2018) Manuel Tonigold et al.   Nature Nanotechnology

Advances in targeting the folate receptor in the treatment/imaging of cancers

(2018) Marcos Fernández et al.   Chemical Science

Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes

(2018) Yuan-Chin Hsieh et al.   Theranostics

Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption

(2018) Juan Guan et al.   Nature Communications

Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles

(2018) Vivian P. Vu et al.   Nature Nanotechnology

Cloaking nanoparticles with protein corona shield for targeted drug delivery

(2018) Jun Yong Oh et al.   Nature Communications

Analysis of nanoparticle delivery to tumours

(2016) Stefan Wilhelm et al.   Nature Reviews Materials

Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review

(2014) Claudia Marchetti et al.   OncoTargets and Therapy

Vintafolide (EC145) for the treatment of folate-receptor-α positive platinum-resistant ovarian cancer

(2014) Allison J Ambrosio et al.   Expert Review of Clinical Pharmacology

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

(2013) R. Wendel Naumann et al.   JOURNAL OF CLINICAL ONCOLOGY

Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface

(2013) Anna Salvati et al.   Nature Nanotechnology

Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition

(2013) A. S. Wibowo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Material properties in complement activation

(2011) S. Moein Moghimi et al.   ADVANCED DRUG DELIVERY REVIEWS

Curvature of Synthetic and Natural Surfaces Is an Important Target Feature in Classical Pathway Complement Activation

(2010) Martin Bjerregård Pedersen et al.   JOURNAL OF IMMUNOLOGY

The human IgM pentamer is a mushroom-shaped molecule with a flexural bias

(2009) D. M. Czajkowsky et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA